We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+5.92%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$214M
AUM Growth
-$1.94M
Cap. Flow
-$12M
Cap. Flow %
-5.58%
Top 10 Hldgs %
39.29%
Holding
99
New
24
Increased
11
Reduced
21
Closed
34

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$7.98M
2
ABBV icon
AbbVie
ABBV
+$4.46M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$4.25M
4
HCA icon
HCA Healthcare
HCA
+$4.22M
5
THC icon
Tenet Healthcare
THC
+$3.84M

Top Sells

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$8.04M
2
CI icon
Cigna
CI
+$6.22M
3
MRK icon
Merck
MRK
+$3.29M
4
PFE icon
Pfizer
PFE
+$3.21M
5
INCY icon
Incyte
INCY
+$3.08M

Sector Composition

Rank Sector Weight
1 Healthcare 67.42%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLXP
26
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$3.39M 1.58%
+27,500
New +$3.04M
VRTX icon
27
CALL
Vertex Pharmaceuticals
VRTX
$133B
$3.31M 1.55%
+35,000
New +$2.45M
LGND icon
28
Ligand Pharmaceuticals
LGND
$5.89B
$3.12M 1.45%
80,150
– –
ELGX
29
DELISTED
Endologix Inc
ELGX
$2.97M 1.38%
19,500
+250
+1% +$33.3K
AMGN icon
30
CALL
Amgen
AMGN
$226B
$2.96M 1.38%
+25,000
New +$2.89M
TRNX
31
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$2.92M 1.36%
125,000
-100,000
-44% -$2.08M
SPNC
32
DELISTED
Spectranetics Corp
SPNC
$2.86M 1.33%
+125,000
New +$2.9M
WMGI
33
DELISTED
Wright Medical Group Inc
WMGI
$2.67M 1.25%
85,000
-15,000
-15% -$448K
TEVA icon
34
Teva Pharmaceuticals
TEVA
$42.1B
$2.62M 1.22%
50,000
– –
CI icon
35
Cigna
CI
$73.6B
$2.3M 1.07%
25,000
-72,500
-74% -$6.22M
IPXL
36
DELISTED
Impax Laboratories, Inc.
IPXL
$2.25M 1.05%
75,000
-70,000
-48% -$1.89M
EW icon
37
PUT
Edwards Lifesciences
EW
$53B
$2.15M 1%
+150,000
New +$2.03M
ABT icon
38
CALL
Abbott
ABT
$188B
$2.04M 0.95%
+50,000
New +$1.96M
BMRN icon
39
BioMarin Pharmaceuticals
BMRN
$13.3B
$2.02M 0.94%
32,500
+7,500
+30% +$453K
ESPR
40
DELISTED
Esperion Therapeutics
ESPR
$1.98M 0.92%
125,000
-10,000
-7% -$144K
NVDQ
41
DELISTED
Novadaq Technologies Inc.
NVDQ
$1.98M 0.92%
120,000
-55,000
-31% -$906K
RARE icon
42
Ultragenyx Pharmaceutical
RARE
$2.64B
$1.88M 0.88%
41,800
-13,200
-24% -$543K
PBYI icon
43
Puma Biotechnology
PBYI
$449M
$1.81M 0.85%
27,500
-7,500
-21% -$533K
ASRT
44
DELISTED
Assertio
ASRT
$1.74M 0.81%
2,083
+416
+25% +$321K
NPSP
45
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$1.74M 0.81%
+52,500
New +$1.52M
SUPN icon
46
CALL
Supernus Pharmaceuticals
SUPN
$2.74B
$1.64M 0.77%
+150,000
New +$1.34M
VNDA icon
47
Vanda Pharmaceuticals
VNDA
$304M
$1.62M 0.75%
100,000
– –
LGND icon
48
PUT
Ligand Pharmaceuticals
LGND
$5.89B
$1.56M 0.73%
+40,075
New +$1.63M
TSRO
49
DELISTED
TESARO, Inc.
TSRO
$1.56M 0.73%
50,000
– –
IPXL
50
PUT
DELISTED
Impax Laboratories, Inc.
IPXL
$1.5M 0.7%
+50,000
New +$1.35M
1
2
3 4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q2 2014 Portfolio in Review

As of Q2 2014, Iguana Healthcare Management held 99 positions worth $214M, down 0.89% from $216M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Iguana Healthcare Management withdrew a net $12M in Q2 2014, closing 34 positions and reducing 21 holdings. Its most notable exit was Zimmer Biomet, an estimated $8.04M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 65% a quarter earlier, followed by Industrials.

Against the trend, Iguana Healthcare Management opened a new position in Celgene Corp worth $9.02M.

  • Iguana Healthcare Management's largest Q2 2014 buy was Celgene Corp: 105,000 shares worth $9.02M.
  • Iguana Healthcare Management added most to Medtronic in Q2 2014, an estimated $2.58M increase.
  • Iguana Healthcare Management's biggest Q2 2014 reduction was Cigna, cutting an estimated $6.22M.
  • Iguana Healthcare Management fully exited Zimmer Biomet in Q2 2014, selling an estimated $8.04M.
  • Iguana Healthcare Management's ten largest holdings make up 39% of its $214M portfolio in Q2 2014.
  • Iguana Healthcare Management opened 24 new positions and closed 34 in Q2 2014.
  • Iguana Healthcare Management's portfolio value fell 0.89% quarter-over-quarter to $214M.

Based on Iguana Healthcare Management's 13F filing for Q2 2014, filed 14 Aug 2014.